Indazole, benzisoxazole, and benzisothiazole kinase inhibitors

Details Indazole, benzisoxazole, and benzisothiazole kinase inhibitors Indazole, benzisoxazole, and benzisothiazole kinase inhibitors

2009-07-22

2011-11-22

Saeed, Kamal (Department: 1626)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

C548S360100

Reexamination Certificate

active

08063091

ABSTRACT:
Compounds having the formulaare useful for inhibiting protein tyrosine kinases. The present invention also discloses methods of making the compounds, compositions containing the compounds, and methods of treatment using the compounds.

REFERENCES:
patent: 5773459 (1998-06-01), Tang et al.
patent: 6177401 (2001-01-01), Ullrich et al.
patent: 6262040 (2001-07-01), Marfat
patent: 6277847 (2001-08-01), Theodoridis et al.
patent: 6524832 (2003-02-01), Kufe et al.
patent: 7070968 (2006-07-01), Kufe et al.
patent: 7297709 (2007-11-01), Dai et al.
patent: 2003/0207870 (2003-11-01), Dumas et al.
patent: 2006/0251734 (2006-11-01), Kufe et al.
patent: 2008/0227827 (2008-09-01), Kawabe et al.
patent: 136745 (1985-04-01), None
patent: 816382 (1959-07-01), None
patent: WO9521613 (1995-08-01), None
patent: WO9623783 (1996-08-01), None
patent: WO9640637 (1996-12-01), None
patent: WO9640673 (1996-12-01), None
patent: WO9737989 (1997-10-01), None
patent: WO9742187 (1997-11-01), None
patent: WO9900357 (1999-01-01), None
patent: WO9932463 (1999-07-01), None
patent: WO0027627 (2000-05-01), None
patent: WO0042012 (2000-07-01), None
patent: WO0119788 (2001-03-01), None
patent: WO0119828 (2001-03-01), None
patent: WO0214311 (2002-02-01), None
patent: WO02055517 (2002-07-01), None
patent: WO02062763 (2002-08-01), None
patent: WO02070494 (2002-09-01), None
patent: WO03051366 (2003-06-01), None
patent: WO03051847 (2003-06-01), None
patent: WO03068228 (2003-08-01), None
patent: WO03087072 (2003-10-01), None
patent: WO03097610 (2003-11-01), None
patent: WO2004010995 (2004-02-01), None
patent: WO2004022544 (2004-03-01), None
patent: WO2004062662 (2004-07-01), None
Adams, et al., “A strategy, for the design of multiplex inhibitors for kinase-mediated signaling in angiogenesis,” Current Opinion in Chemical Biology, 2002, 6 (4), 486-492.
Cullinan-Bove et al., “Vascular endothelial growth factor/vascular permeability factor expression in the rat uterus: rapid stimulation by estrogen correlates with estrogen-inuced increases in uterine capillary permeability and growth,” Endrocinology, 1993, 133 (2), pp. 829-837.
Derbyshire, et al., “Anti-tumor and anti-angiogenic effects in mice of heparin conjugated to angiostatic steroids,” Int. J. Cancer, 1995, 63 (5), 694-701.
Mongin et al., “Regioselective ortho-lithiation of chloro and bromo substituted fluoroarenes,” Tetrahedron Letters, 1996, 37 (36), 6551-6554.
Passaniti, A. et al., “Methods in Laboratory Investigation/A Simple, Quantitative Method for Assessing Angiogenesis and Antiangiogenic Agents Using Reconstituted Basement Membrane, Heparin, and Fibroblast Growth Factor,” Lab. Invest, 1992, 67 (4), 519-528.
PCT International search report for application No. PCT/US2004/016166 mailed on Nov. 8, 2004, 2 pages.
Rupert, et al., “Suzuki Couplings with Phthalimidines—An Efficient Route to Staurosporinone analogs,” Heterocycles, 1997, 45 (11), 2217-2221.
Silvagno et al., “In Vivo Activation of met Tyrosine Kinase by Heterodimeric Hepatocyte Growth Factor Molecule Promotes Angiogenesis,” Arterioselerosis, Thrombosis, and Vascular Biology,1995, 15 (11), 1857-1865.
Songyang et al., “Catalytic specificity of protein-tyrosine kinases is critical for selective signalling,” Nature, 1995, 373, 536-539.
Thistlethwaite et al., “Human angiopoietin gene expression is a marker for severity of pulmonary hypertension in patients undergoing pulmonary thromboendarterectomy,” Journal of Thoracic and Cardiovascular Surgery, 2001, 122 (1), pp. 65-73.
Tyle, “Iontophoretic Devices for Drug Delivery,” Pharmaceutical Research, 1986, 3 (6), pp. 318-326.
Voller et al., “Enzyme-Linked Immunosorbent Assay,” in: Manual of clinical immunology, Rose N.R. & Friedman H., eds., American Society of Microbiology, 1980, 2nd ed., pp. 359-371.
Wilson et al., “Human prostate tumor angiogenesis in nude mice: metalloprtoease and plasminogen activator activities during tumor growth and neovasularization of subcutaneously injected matrigel impregnated with human prostate tumor cells,” Anat. Rec., 1997, 249 (1), pp. 63-73.

Affiliated with

Also associated with

Rating

Indazole, benzisoxazole, and benzisothiazole kinase inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Indazole, benzisoxazole, and benzisothiazole kinase inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Indazole, benzisoxazole, and benzisothiazole kinase inhibitors will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4285449